Partner Content Partner Content Poor Glycaemic Control and Tooth Loss Study Poor Glycaemic Control and Tooth Loss Study
Partner Content Partner Content First results of the DiabetRisk study First results of the DiabetRisk study
News Lilly's 'triple G' retatrutide aces crucial obesity trial Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
